[1]
Calisanie, M.A.M.O.P. et al. 2026. Anti-VEGF Therapy in Diabetic Retinopathy: A Synthesis of Efficacy, Durability, and a Clinical Decision-Making Framework in the Context of Developing Countries. Dinasti Health and Pharmacy Science. 4, 1 (Sep. 2026), 157–169. DOI:https://doi.org/10.38035/dhps.v4i1.3850.